Brief: Asit Biotech H1 Operating Loss Widens To 7.8 Million Euros

European Medical Solutions SA

18/09/2019 06:16

Sept 18 (Reuters) - ASIT BIOTECH SA  ASIT.BR :
    * ASIT BIOTECH PRESENTS ITS 2019 HALF YEAR RESULTS AND PROVIDES FURTHER UPDATE ON ITS
CLINICAL
PROGRAMS UNTIL END-2019
    * CASH POSITION OF EUR 2.5 MILLION AS OF 30 JUNE 2019
    * CASH BURN OF EUR 6.0 MILLION IN FIRST HALF OF 2019
    * H1 NET LOSS EUR 7.8 MILLION VERSUS LOSS OF EUR 5.4 MILLION YEAR AGO
    * H1 OPERATING LOSS EUR 7.8 MILLION VERSUS LOSS OF EUR 5.4 MILLION YEAR AGO
    * ON 30 JUNE 2019 COMPANY HAD A CASH POSITION OF EUR 2.5 MILLION
    * THE COMPANY EXPECTS THE PRECLINICAL PACKAGE OF THE PNT-ASIT+TM DRUG CANDIDATE FOR PEANUT
ALLERGY
TO BE READY BY YEAR END

Source text for Eikon:  ID:nBw6k5gKga 
Further company coverage:  ASIT.BR 

 (Gdynia Newsroom)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))